BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8508392)

  • 1. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
    McKearn TJ
    Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N
    Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioimmunoscintigraphy and radioimmunotherapy--approaches towards future aspects].
    Nakamura K
    Kaku Igaku; 1994 Sep; 31(9):1133-40. PubMed ID: 7967199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.
    Sakahara H; Onodera H; Shirato M; Yao Z; Ohshio G; Kobayashi H; Hosono M; Yano S; Nakada H; Imamura M
    Cancer Immunol Immunother; 1995 Sep; 41(3):157-61. PubMed ID: 7553684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
    Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
    J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoscintigraphy in primary colorectal cancer.
    Ryan JW
    Cancer; 1993 Jun; 71(12 Suppl):4217-24. PubMed ID: 8508383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years with monoclonal antibodies: State of the art--Where do we go?
    Stigbrand T; Ullén A; Sandstrom P; Mirzaie-Joniani H; Sundström B; Nillson B; Arlestig L; Norrlund RR; Ahlström KR; Hietala S
    Acta Oncol; 1996; 35(3):259-65. PubMed ID: 8679254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabody Pretargeting with Click Chemistry In Vivo.
    van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
    J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
    Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
    Zhu H; Jain RK; Baxter LT
    J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.
    Hornick JL; Sharifi J; Khawli LA; Hu P; Bai WG; Alauddin MM; Mizokami MM; Epstein AL
    J Nucl Med; 2000 Feb; 41(2):355-62. PubMed ID: 10688122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel strategies to enhance monoclonal antibodies targeting.
    Khawli LA; Epstein AL
    Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
    Stipsanelli E; Valsamaki P
    Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.
    Nakada K; Sakamoto J; Watanabe T; Itoh K; Akiyama S; Takagi H
    Jpn J Cancer Res; 1997 Jun; 88(6):605-13. PubMed ID: 9263539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in antibody imaging in colorectal cancer.
    Tempero M
    Cancer; 1993 Jun; 71(12 Suppl):4248-51. PubMed ID: 8508387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.